ArticleJournal of experimental & clinical cancer research : CR2019

Discovery and evaluation of ZT55, a novel highly-selective tyrosine kinase inhibitor of JAK2

Min Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.